Related Experiment Video

Updated: Aug 13, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
09:01

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

Ultra-early hemostatic therapy for acute intracerebral hemorrhage

Stephan A Mayer1, Fred Rincon

  • 1Neurological Intensive Care Unit, Columbia-Presbyterian Medical Center, New York, NY, USA. sam14@columbia.edu

Seminars in Hematology
|January 24, 2006
PubMed

Insights

Intracerebral hemorrhage (ICH) treatment with recombinant activated factor VII (rFVIIa) reduced hematoma growth by 50%. This ultra-early hemostatic therapy significantly decreased mortality and improved outcomes in ICH patients.

Area of Science:

  • Neurology
  • Hematology
  • Emergency Medicine

Background:

  • Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality and disability.
  • Early hematoma growth is a primary driver of neurological deterioration and mortality in ICH.
  • Current treatments for ICH are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To evaluate the efficacy of ultra-early hemostatic therapy using recombinant activated factor VII (rFVIIa) in reducing hematoma growth and improving outcomes in ICH patients.
  • To assess the safety and effectiveness of different rFVIIa dosages administered within 4 hours of ICH onset.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 399 ICH patients.
  • Patients received a single dose of rFVIIa (40, 80, or 160 microg/kg) or placebo within 4 hours of symptom onset.
  • Hematoma growth was assessed using computed tomography, and clinical outcomes including mortality and functional status were evaluated.

Main Results:

  • rFVIIa administration significantly reduced hematoma growth by approximately 50% compared to placebo.
  • Patients treated with rFVIIa showed a 38% reduction in 30-day mortality.
  • Improved functional outcomes were observed among survivors treated with rFVIIa.

Conclusions:

  • Ultra-early hemostatic therapy with rFVIIa is a promising intervention for minimizing hematoma expansion in ICH.
  • rFVIIa treatment significantly improves survival rates and functional recovery in patients with intracerebral hemorrhage.
  • Further investigation in ongoing Phase III trials is crucial to confirm these findings and optimize rFVIIa dosage.

More Related Videos

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice07:02

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Published on: August 24, 2011

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...